During the last session, Mega Matrix Inc (AMEX:MPU)’s traded shares were 0.38 million, with the beta value of the company hitting 3.03. At the end
During the last session, Byrna Technologies Inc (NASDAQ:BYRN)’s traded shares were 0.41 million, with the beta value of the company hitting 1.67. At the end
During the last session, Gain Therapeutics Inc (NASDAQ:GANX)’s traded shares were 0.36 million, with the beta value of the company hitting 0.14. At the end
During the last session, Bio-Path Holdings Inc (NASDAQ:BPTH)’s traded shares were 0.34 million, with the beta value of the company hitting 0.07. At the end
During the last session, Biodesix Inc (NASDAQ:BDSX)’s traded shares were 0.35 million, with the beta value of the company hitting 1.09. The 52-week high for
During the last session, Cellectis ADR (NASDAQ:CLLS)’s traded shares were 0.33 million, with the beta value of the company hitting 3.06. At the end of
During the last session, Organogenesis Holdings Inc (NASDAQ:ORGO)’s traded shares were 0.31 million, with the beta value of the company hitting 1.77. At the end
During the last session, BioAge Labs Inc (NASDAQ:BIOA)’s traded shares were 0.85 million. At the end of the trading day, the stock’s price was $5.82,
During the last session, Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s traded shares were 0.37 million, with the beta value of the company hitting -2.90. At the
During the last session, NeoVolta Inc (NASDAQ:NEOV)’s traded shares were 0.34 million, with the beta value of the company hitting -0.39. At the end of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
